Connor, Clark & Lunn Investment Management Ltd. United Therapeutics Corp Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$18.8 Billion
Q3 2024

A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in United Therapeutics Corp stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 10,959 shares of UTHR stock, worth $3.99 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

10,959

Previous 53,497 79.51%

Holding current value

$3.99 Million

Previous $17 Million 76.96%

% of portfolio

0.02%

Previous 0.08%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$311.04 - $363.55 $13.2 Million - $15.5 Million	-42,538 Reduced 79.51%	10,959 $3.93 Million
Q2 2024 Aug 09, 2024	BUY	$228.26 - $319.04 $11 Million - $15.3 Million	48,105 Added 892.16%	53,497 $17 Million
Q1 2024 May 09, 2024	BUY	$210.76 - $249.51 $1.14 Million - $1.35 Million	5,392 New	5,392 $1.24 Million
Q4 2022 Feb 10, 2023	SELL	$205.95 - $280.43 $11.1 Million - $15.1 Million	-53,934 Reduced 94.98%	2,853 $793,000
Q3 2022 Nov 10, 2022	SELL	$203.3 - $244.17 $939,449 - $1.13 Million	-4,621 Reduced 7.53%	56,787 $11.9 Million
Q2 2022 Aug 05, 2022	BUY	$174.81 - $241.14 $1.5 Million - $2.08 Million	8,606 Added 16.3%	61,408 $14.5 Million
Q1 2022 May 12, 2022	BUY	$166.16 - $213.96 $2.24 Million - $2.89 Million	13,507 Added 34.37%	52,802 $9.47 Million
Q4 2021 Feb 10, 2022	BUY	$184.32 - $216.08 $4.44 Million - $5.21 Million	24,105 Added 158.69%	39,295 $8.49 Million
Q3 2021 Nov 12, 2021	BUY	$179.86 - $214.88 $2.73 Million - $3.26 Million	15,190 New	15,190 $2.8 Million
Q1 2021 May 13, 2021	SELL	$153.94 - $174.85 $655,476 - $744,511	-4,258 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$101.87 - $151.79 $433,762 - $646,321	4,258 New	4,258 $646,000
Q4 2019 Feb 12, 2020	SELL	$78.31 - $95.34 $3.51 Million - $4.28 Million	-44,858 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$74.85 - $85.99 $1.81 Million - $2.08 Million	-24,217 Reduced 35.06%	44,858 $3.58 Million
Q2 2019 Aug 07, 2019	BUY	$76.06 - $120.81 $3.8 Million - $6.04 Million	49,975 Added 261.65%	69,075 $5.39 Million
Q1 2019 May 08, 2019	SELL	$107.15 - $126.84 $2.79 Million - $3.31 Million	-26,075 Reduced 57.72%	19,100 $2.24 Million
Q4 2018 Feb 12, 2019	SELL	$101.4 - $128.73 $1.02 Million - $1.29 Million	-10,025 Reduced 18.16%	45,175 $4.92 Million
Q3 2018 Nov 13, 2018	SELL	$113.81 - $129.46 $1.82 Million - $2.07 Million	-15,974 Reduced 22.44%	55,200 $7.06 Million
Q2 2018 Aug 02, 2018	BUY	$101.14 - $118.31 $93,554 - $109,436	925 Added 1.32%	71,174 $8.05 Million
Q1 2018 May 14, 2018	SELL	$107.21 - $151.94 $1.11 Million - $1.57 Million	-10,364 Reduced 12.86%	70,249 $7.89 Million
Q4 2017 Feb 09, 2018	SELL	$118.58 - $151.28 $1.48 Million - $1.89 Million	-12,483 Reduced 13.41%	80,613 $11.9 Million
Q3 2017 Nov 14, 2017	BUY	$114.6 - $136.81 $2.59 Million - $3.09 Million	22,596 Added 32.05%	93,096 $10.9 Million
Q2 2017 Aug 14, 2017	BUY	N/A	70,500	70,500 $9.15 Million

Others Institutions Holding UTHR

# of Institutions

668

Shares Held

42.8M

Call Options Held

194K

Put Options Held

295K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.6B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account

Connor, Clark & Lunn Investment Management Ltd. United Therapeutics Corp Transaction History